| Kim Sandell |
Project Director |
Pfizer |
| Dr. Michael Dieterle |
Associate Director Purification Development |
Boehringer Ingelheim |
| Patrick DhaesePhD |
Vice President CMC Operations |
ActoGeniX NV |
| Dr Gabriele Reichmann |
Scientific Assessor (Quality, Non-clinical), Section Mono – and Polyclonal Antibodie |
Paul-Ehrlich Institute |
| Zorica Dragic |
Principal Scientist Cell and Process R&D |
Novartis Pharma AG |
| Dr. Eli Keshavarz-Moore |
Reader in Biochemical Engineering the Advanced Centre for Biochemical Engineering Department of Biochemical Engineering |
University College London |
| Jan Visser |
Head Technical Development |
BPO Sandoz |
| Dr. Ronan O'Kennedy |
Investigator/ Team Leader BioProcess Development BioPharmaceutical CEDD |
GlaxoSmithKline |
| Chiron Howell |
Process Scientist |
Protherics |
| Dr. Andy Pickett |
Senior Director Biologicals Science and Technology |
Ipsen Biopharm Ltd. |
| Christine Lattenmayer |
Group Head Cell Biology & Media Development |
Sandoz |
| Sharon Grimster |
Director of Technical and Business Operations |
Antisoma plc |
| Dr. Felix Oehme |
Group Leader/ Project Manager Global Biological Development |
Bayer HealthCare AG |
| Prof. Ian A. Sutherland |
Director Brunel Institute for Bioengineering |
Brunel University |
| Dr. Annie van Broekhoven |
Vice President |
Innogenetics Biologicals |
| Dr. Kevin Bailey |
Vice President Preclinical Manufacturing and Process Development |
Regeneron Pharmaceuticals Inc. |
| Dr. Marcel de Vocht |
Manager DSP |
Crucell |
| Bill Thompson |
Consultant |
Rotherwood Associates |